<DOC>
	<DOCNO>NCT02202850</DOCNO>
	<brief_summary>Determine remission criterion Month 6 predicts remission Month 12 best .</brief_summary>
	<brief_title>Defining Remission With Etanercept AS Real Life Clinical Practice</brief_title>
	<detailed_description>The analysis primary endpoint base logistic regression define dependent variable remission Month 12 6 independent variable ASAS partial remission , ASAS 5/6 , ASAS60 , ASAS40 , BASDAI50 ASDAS inactive disease status . This analysis conduct arm study well pool patient group . In context seem reasonable ensure completion study total approximate number 100 patient ( approximately 50 patient per arm ) . In order ensure 50 completers arm , 70 patient recruited baseline , take account drop-out rate 30 % 1 year period .</detailed_description>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>1 . Patients AS start treatment Etanercept accord prevail reimbursement criterion dose line SmPC . 1 . First cohort : Etanercept first biological product prescribe 2 . Second cohort : Etanercept second biological product prescribe 2 . Capable understanding willing provide sign dated write , voluntary inform consent protocolspecific procedure perform . 3 . 18 year age old time consent 4 . Evidence personally sign date informed consent document indicate patient ( legally acceptable representative ) inform pertinent aspect study . 1 . History current psychiatric illness would interfere subject 's ability comply protocol requirement give informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>